Long-term clinical trial results support the use of paclitaxel once weekly and docetaxel once every 3 weeks following chemotherapy in women with stage II or III operable breast cancer.
Medscape Medical News …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
